Safety of GLP ‐1 and Dual GLP ‐1/ GIP Receptor Agonists in Preconception, Pregnancy, and Lactation: A Systematic Review of Maternal, Fetal, and Neonatal Outcomes

Documenti analoghi

• Efficacy and safety of GLP ‐1 receptor agonists and SGLT2 inhibitors as adjuncts to insulin in type 1 diabetes: Systematic review and meta‐analysis
  di: Sama M. Abdel‐Rahman, et al.
  Pubblicazione: (2026)
• Interpreting Pregnancy Risk After GLP ‐1 Receptor Agonists Discontinuation
  di: Roberta Scairati, et al.
  Pubblicazione: (2026)
• Dietary Strategies and Nutritional Management in Patients Receiving GLP ‐1 and Dual GIP / GLP ‐1 Receptor Agonists as Adjuncts to Lifestyle Interventions: A Systematic Review of Randomised Clinical Trials
  di: Rayanne Santos de Paulo, et al.
  Pubblicazione: (2026)
• Efficacy of Tirzepatide Dual GIP / GLP ‐1 Receptor Agonist in Patients With Idiopathic Intracranial Hypertension. A Real‐World Propensity Score‐Matched Study
  di: Ahmed Y. Azzam, et al.
  Pubblicazione: (2025)
• Association of GLP ‐1 Receptor Agonists With Hepatic Decompensation in the All of Us Research Program
  di: Inyoung Hwang, et al.
  Pubblicazione: (2026)